Login / Signup

Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta.

Jannie D HaldCatriona KeerieChristopher J WeirMuhammad K JavaidWayne LamPatricia OsborneJennifer WalshBente Lomholt LangdahlStuart H Ralston
Published in: BMJ open (2023)
ISRCTN15313991.
Keyphrases
  • randomized controlled trial
  • study protocol
  • bone mineral density
  • open label
  • hip fracture